I'll buy all of that excepT for the part where he told us two weeks ago in his blog that he may wait until NYC instead of copenhagen to release data. In doing so he implied that he had the numbers, now he tells us he needs a bridge study to get us there. It seems his credibility is on the line.
I am way long and a significant shareholder. Please splain this to me so I don't question the veracity of his word. This is not a bash, just a noteworthy concern, again, again and again.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links